Codexis Company Description

Codexis, Inc. discovers, develops, and sells enzymes and other proteins.

The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services.

The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.

The company’s platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency.

The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe.

The company was incorporated in 2002 and is headquartered in Redwood City, California.

Codexis, Inc.

Country	United States
Founded	2002
Industry	Biotechnology
Sector	Healthcare
Employees	174
CEO	Stephen Dilly

Contact Details

Address: 200 Penobscot Drive Redwood City, Delaware 94063 United States
Phone	650 421 8100
Website	codexis.com

Stock Details

Ticker Symbol	0I0X
Exchange	London Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US1920051067
SIC Code	2836

Key Executives

Name	Position
Dr. Stephen George Dilly MBBS, Ph.D.	President, Chief Executive Officer and Chairman
Kevin Norrett M.B.A., M.S.	Chief Operating Officer
Georgia L. Erbez	Chief Financial Officer
Carrie McKim	Director of Investor Relations
Karen Frechou-Armijo	Senior Vice President and Head of Human Resources
Dr. Stefan Lutz Ph.D.	Senior Vice President of Research
John Schiffhauer	Senior Vice President of Intellectual Property